These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Flow cytometric analysis of consecutive lymph node samples from patients with Hodgkin's disease: reproducible within one biopsy? Pasman PC; Erdkamp FL; Breed WP; Janssen WC; Hoffmann JJ; Schutte B; Vrints LW; Schouten HC Leuk Lymphoma; 1996 Jul; 22(3-4):339-44. PubMed ID: 8819084 [TBL] [Abstract][Full Text] [Related]
6. Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue. Erdkamp FL; Schouten HC; Breed WP; Janssen WC; Hoffmann JJ; Reynders M; Schutte B; Blijham GH Hematol Pathol; 1994; 8(3):75-84. PubMed ID: 7982854 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma. Wu HM J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of DNA ploidy and proliferative activity in Hodgkin's disease. Joensuu H; Klemi PJ; Korkeila E Am J Clin Pathol; 1988 Dec; 90(6):670-3. PubMed ID: 3195496 [TBL] [Abstract][Full Text] [Related]
9. DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation. Anastasi J; Bauer KD; Variakojis D Am J Pathol; 1987 Sep; 128(3):573-82. PubMed ID: 3307446 [TBL] [Abstract][Full Text] [Related]
10. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma. Joensuu H; Ristamäki R; Söderström KO; Jalkanen S J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators. Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595 [TBL] [Abstract][Full Text] [Related]
12. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome. Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma. Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group. Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525 [TBL] [Abstract][Full Text] [Related]
15. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
17. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study. Russo A; Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Latteri F; Valerio MR; Pantuso G; Morello V; Dardanoni G; Latteri MA; Colucci G; Tomasino RM; Gebbia N Cancer; 2001 Jul; 92(2):294-302. PubMed ID: 11466682 [TBL] [Abstract][Full Text] [Related]
18. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis. Takashima S; Sone S; Horii A; Okamoto S; Yoshida J AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200 [TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345 [TBL] [Abstract][Full Text] [Related]
20. DNA content analysis of fine needle aspirates obtained from lymphatic tissue. Alanen KA; Joensuu H; Klemi PJ Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]